XWELL (NASDAQ:XWEL) Posts Quarterly Earnings Results, Misses Expectations By $0.51 EPS

XWELL (NASDAQ:XWEL) posted its earnings results on Wednesday. The company reported ($1.51) earnings per share for the quarter, missing the consensus estimate of ($1.00) by ($0.51), Zacks reports. XWELL had a negative net margin of 58.17% and a negative return on equity of 352.37%.

XWELL Price Performance

XWEL remained flat at $1.46 on Wednesday. The company’s stock had a trading volume of 48,469 shares, compared to its average volume of 5,649,626. The stock’s 50-day moving average is $1.28 and its 200 day moving average is $0.88. The firm has a market cap of $11.58 million, a PE ratio of -0.29 and a beta of 1.01. XWELL has a 12-month low of $0.26 and a 12-month high of $2.20.

Wall Street Analysts Forecast Growth

XWEL has been the subject of several analyst reports. Wall Street Zen downgraded XWELL from a “hold” rating to a “sell” rating in a research note on Sunday. Weiss Ratings downgraded XWELL from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, May 13th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of “Sell”.

About XWELL

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.